Schedule 13G ownership disclosure
CYTOMED THERAPEUTICS LIMITED
Security class unavailable · CUSIP: Y1R80M106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-006596
- Form type
- SC 13G
- Filer
- CytoMed Therapeutics Ltd
- CIK
- CIK 1873093
- Filed
- Feb 14, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership